Journal of the Chemical Society, Dalton Transactions p. 3603 - 3608 (1996)
Update date:2022-08-03
Topics:
Fernandez, Eduardo J.
Gimeno, M. Concepcion
Jones, Peter G.
Laguna, Antonio
Laguna, Mariano
Olmos, Elena
Treatment of [M(CO)4{(Ph2PCH2)2CMe(CH 2PPh2)}] (M = Mo or W) with neutral or cationic gold-(I) or -(III) derivatives afforded bi- or tri-nuclear complexes containing the triphosphine (Ph2PCH2)3CMe (tdppme) acting as a μ-P,P′,P″ ligand, a co-ordination mode poorly represented thus far. The binuclear derivative [(OC)4Mo(tdppme)AuCl] further reacts with 1 equivalent of Tl(acac) (acac = acetylacetonate) to afford [(OC)4Mo(tdppme)Au(acac)]. This complex acts as a deprotonating agent in reactions with various starting materials containing phosphines such as (Ph2P)2CH2 or (Ph2P)3CH, leading to the formation of trinuclear methanide complexes. The crystal structure of [(OC)4Mo(tdppme)AuCl] has been established by X-ray crystallography.
View MoreTaizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
WUHU HUAHAI BIOLOGY ENGINEERING CO LTD
Contact:+86-553-3836920
Address:7/F NO.82 LAODONG ROAD WUHU CHINA
Contact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Xi'an caijing Opto-Electrical Science & Technology Co., LTD
Contact:+86-29-88294447
Address:NO.168 Zhangba Rd. East, Xi'an, P.R.China
Doi:10.1016/0040-4039(96)01758-3
(1996)Doi:10.1039/c39800000980
(1980)Doi:10.1063/1.1671734
(1969)Doi:10.1002/ejoc.202000837
(2020)Doi:10.1016/j.tetlet.2011.11.051
(2012)Doi:10.1002/1521-3773(20011203)40:23<4441::AID-ANIE4441>3.0.CO;2-I
(2001)
